Results 21 to 30 of about 1,997,745 (357)

Women's knowledge and use of prenatal screening tests

Journal of Clinical Nursing, 2017
Memnun Seven, Aygul Akyuz, Kafiye Eroglu   +2 more
exaly   +2 more sources

Contingent prenatal screening for frequent aneuploidies with cell-free fetal DNA analysis

Taiwanese Journal of Obstetrics & Gynecology, 2021
Objective: To analyze the results of contingent screening for common aneuploidies at our center from June 2017 to June 2019. Materials and methods: Traditional screening tests were performed using a combination of biochemical markers and ultrasound ...
M. Rosario Torres Aguilar, Pilar Carrasco Salas, Cristina Santos Rosa, Guadalupe Bueno Rodríguez, Eduardo Martínez-Bonet, Práxedes Carreto Alba, Antonio León-Justel, M. Reyes Granell Escobar   +7 more
doaj   +1 more source

Clinical experience with non‐invasive prenatal screening for single‐gene disorders

Ultrasound in Obstetrics and Gynecology, 2021
To assess the performance of a non‐invasive prenatal screening test (NIPT) for a panel of dominant single‐gene disorders (SGD) with a combined population incidence of 1 in 600.
P. Mohan, J. Lemoine, C. Trotter, I. Rakova, P. Billings, S. Peacock, C. Kao, Y. Wang, F. Xia, C. Eng, P. Benn   +10 more
semanticscholar   +1 more source

Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18

Scientific Reports, 2022
To evaluate the clinical predictive value of serum alpha-fetoprotein variants (AFP-L2, AFP-L3) in combination with maternal serum prenatal screening biomarkers in predicting fetal trisomy 21 and trisomy 18. We analyze the data of singleton pregnant women
Yiming Chen, Yijie Chen, Wenwen Ning, Wen Zhang, Liyao Li, Xiaoying Wang, Yixuan Yin, Huimin Zhang   +7 more
doaj   +1 more source

Ethical issues associated with prenatal screening using non‐invasive prenatal testing for sex chromosome aneuploidy

Prenatal Diagnosis, 2022
Prenatal screening for sex chromosome aneuploidies (SCAs) is increasingly available through expanded non‐invasive prenatal testing (NIPT). NIPT for SCAs raises complex ethical issues for clinical providers, prospective parents and future children.
Johnston Molly, Warton Chanelle, Pertile Mark, Taylor-Sands Michelle, Delatycki Martin B, Hui Lisa, Savulescu Julian, Mills Catherine   +7 more
semanticscholar   +1 more source

Universal prenatal screening: a initiative from Guanajuato, Mexico to improve equity in perinatal healthcare

Frontiers in Medicine, 2023
The prenatal approach from a preventive perspective is necessary to reduce perinatal complications. A perinatal care model with a holistic and horizontal approach is required.
Ma de la Luz Bermudez Rojas, Virginia Medina Jimenez, Javier Ivan Manzanares Cuadros, Daniel Alberto Diaz Martínez, Nicolas Padilla Raygoza, Elia Lara Lona   +5 more
doaj   +1 more source

A decade of non‐invasive prenatal screening in Australia: National impact on prenatal screening and diagnostic testing

Australian and New Zealand journal of obstetrics and gynaecology, 2022
Prenatal screening for aneuploidy has undergone immense changes over the past two decades. In 2013 cell‐free DNA‐based non‐invasive prenatal testing (NIPT) became a new self‐funded option primarily for Down syndrome screening, but also other aneuploidies
L. Hui, J. Halliday
semanticscholar   +1 more source

Routinization of prenatal screening with the non-invasive prenatal test: pregnant women’s perspectives

European Journal of Human Genetics, 2021
Due to the favorable test characteristics of the non-invasive prenatal test (NIPT) in the screening of fetal aneuploidy, there has been a strong and growing demand for implementation.
K. V. D. van der Meij, Annabel Njio, Linda Martin, J. T. Gitsels-van der Wal, M. Bekker, E. V. van Vliet-Lachotzki, A. van der Ven, A. Kater-Kuipers, D. Timmermans, E. Sistermans, R. Galjaard, L. Henneman   +11 more
semanticscholar   +1 more source

Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome.

American Journal of Obstetrics and Gynecology, 2022
BACKGROUND Prenatal screening has historically focused primarily on detection of fetal aneuploidies. Cell-free DNA (cfDNA) now enables noninvasive screening for subchromosomal copy number variants, including 22q11.2 deletion syndrome (22q11.2DS or ...
P. Dar, Bo Jacobson, R. Clifton, M. Egbert, F. Malone, R. Wapner, A. Roman, A. Khalil, R. Faro, R. Madankumar, L. Edwards, N. Strong, S. Haeri, R. Silver, N. Vohra, J. Hyett, Z. Demko, K. Martin, M. Rabinowitz, K. Flood, Y. Carlsson, G. Doulaveris, S. Daly, Maria Hallingström, Cora Macpherson, Charlly Kao, H. Hakonarson, M. Norton   +27 more
semanticscholar   +1 more source

New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age

BMC Pregnancy and Childbirth, 2020
Background To determine whether advanced maternal age (AMA) causes changes in the maternal serum markers of Trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester of pregnancy.
Yiming Chen, Xue Wang, Liyao Li, Sha Lu, Zhifen Zhang   +4 more
doaj   +1 more source